A Prospective, Randomized Trial of Autologous Bone Marrow Transplantation and Chemotherapy in Multiple Myeloma, New England Journal of Medicine, vol.335, issue.2, pp.91-97, 1996. ,
DOI : 10.1056/NEJM199607113350204
Stem cell transplantation in multiple myeloma (0, 1, or 2), Current Opinion in Oncology, vol.17, issue.2, pp.93-98, 2005. ,
DOI : 10.1097/01.cco.0000152978.32304.37
Autologous stem cell transplantation in hematological malignancies, Springer Seminars in Immunopathology, vol.26, issue.1-2, pp.3-30, 2004. ,
DOI : 10.1007/s00281-004-0172-4
Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's Lymphoma, New England Journal of Medicine, vol.333, issue.23, pp.1540-1545, 1995. ,
DOI : 10.1056/NEJM199512073332305
Haematopoietic stem cell transplantation (HSCT) in Europe 2002. Changes in indication and impact of team density. A report of the EBMT activity survey, Bone Marrow Transplantation, vol.34, issue.10, pp.855-875, 2002. ,
DOI : 10.1038/sj.bmt.1704653
Optimization of Peripheral Blood Stem Cell Mobilization, Stem Cells, vol.90, issue.1, pp.106-116, 1996. ,
DOI : 10.1002/stem.140106
Harvesting and enrichment of HPC mobilized into the peripheral blood of normal donors by GM-CSF or G-CSF: potential role in allogenic transplantation, Blood, vol.85, pp.275-282, 1995. ,
Comparative effect of GM-CSF and G-CSF on priming of peripheral blood progenitor cells for use with autologous bone marrow after high dose chemotherapy, Blood, vol.81, pp.1709-1719, 1993. ,
Comparison between granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in the mobilization of peripheral blood stem cells, Current Opinion in Hematology, vol.9, issue.3, pp.190-198, 2002. ,
DOI : 10.1097/00062752-200205000-00003
Biologic effects and potential clinical applications of Flt3 ligand, Current Opinion in Hematology, vol.5, issue.3, pp.192-196, 1998. ,
DOI : 10.1097/00062752-199805000-00008
Autografting with peripheral blood stem cells mobilized by sequential interleukin-3/granulocyte-macrophage colony-stimulating factor following high-dose chemotherapy in non-Hodgkin's lymphoma, Bone Marrow Transplant, vol.12, pp.643-652, 1993. ,
A randomized phase 2 study of PBPC mobilization by stem cell factor and filgrastim in heavily pretreated patients with Hodgkin???s disease or non-Hodgkin???s lymphoma, Bone Marrow Transplantation, vol.26, issue.5, pp.471-481, 2000. ,
DOI : 10.1038/sj.bmt.1702531
Randomized Cross-Over Trial of Progenitor-Cell Mobilization: High-Dose Cyclophosphamide Plus Granulocyte Colony-Stimulating Factor (G-CSF) Versus Granulocyte-Macrophage Colony-Stimulating Factor Plus G-CSF, Journal of Clinical Oncology, vol.18, issue.9, pp.1824-1830, 2000. ,
DOI : 10.1200/JCO.2000.18.9.1824
Peripheral blood stem cell mobilization with cyclophosphamide in combination with G-CSF, GM-CSF, or sequential ,
Cells and Lymphoma Cells in Non-Hodgkin's Lymphoma Patients Mobilized with Different Growth Factors, Journal of Hematotherapy & Stem Cell Research, vol.10, issue.1, pp.167-176, 2001. ,
DOI : 10.1089/152581601750098453
Emerging applications of recombinant human granulocyte-macrophage colony-stimulating factor, Blood, vol.92, pp.4491-4508, 1998. ,
The ISHAGE Guidelines for CD34+ Cell Determination by Flow Cytometry, Journal of Hematotherapy, vol.5, issue.3, pp.213-226, 1996. ,
DOI : 10.1089/scd.1.1996.5.213
The Mi15 monoclonal antibody (anti-syndecan-1) is a reliable marker for quantifying plasma cells in paraffin-embedded bone marrow biopsy specimens, Human Pathology, vol.30, issue.12, pp.1405-1411, 1999. ,
DOI : 10.1016/S0046-8177(99)90160-0
Predictive factors for long-term engraftment of autologous blood stem cells, Bone Marrow Transplantation, vol.26, issue.12, pp.1299-1304, 2000. ,
DOI : 10.1038/sj.bmt.1702708
Colony-Stimulating Factors and Peripheral Blood Progenitor Cell Transplantation, PharmacoEconomics, vol.10, issue.1, pp.23-35, 1996. ,
DOI : 10.2165/00019053-199610010-00004
Factors that influence collection and engraftment of autologous peripheral-blood stem cells., Journal of Clinical Oncology, vol.13, issue.10, pp.2547-2555, 1995. ,
DOI : 10.1200/JCO.1995.13.10.2547
High CD34 (+) cell counts decrease hematologic toxicity of autologous peripheral blood progenitor cell transplantation, Blood, vol.91, pp.3148-3155, 1998. ,
Subsets of CD34+ cells and rapid hematopoietic recovery after peripheral-blood stem-cell transplantation., Journal of Clinical Oncology, vol.13, issue.8, pp.1922-1932, 1995. ,
DOI : 10.1200/JCO.1995.13.8.1922